pharmaceuticals-and-healthcare

United States Neuromodulation Market Report 2016


Published On : Oct 2016

Category : Biotechnology

No. of Pages : 117 pages

  • $3800
  • $7600

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of Neuromodulation
Revenue, means the sales value of Neuromodulation

This report studies sales (consumption) of Neuromodulation in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Medtronic, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
St. Jude Medical, Inc. (U.S.)
Synapse Biomedical, Inc. (U.S.)
Nevro Corporation (U.S.)
Neurosigma, Inc. (U.S.)
Neuropace, Inc. (U.S.).
Neuronetics, Inc. (U.S.)
Cyberonics, Inc. (U.S.)
BioControl Medical (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Internal Neuromodulation
External Neuromodulation
Type III
Split by applications, this report focuses on sales, market share and growth rate of Neuromodulation in each application, can be divided into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation Market

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The United states neuromodulation market report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the United states neuromodulation market report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the United states neuromodulation market report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

United States Neuromodulation Market Report 2016
1 Neuromodulation Overview
1.1 Product Overview and Scope of Neuromodulation
1.2 Classification of Neuromodulation
1.2.1 Internal Neuromodulation
1.2.2 External Neuromodulation
1.2.3 Type III
1.3 Application of Neuromodulation
1.3.1 Spinal Cord Stimulation
1.3.2 Deep Brain Stimulation
1.3.3 Sacral Nerve Stimulation
1.3.4 Vagus Nerve Stimulation Market
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Neuromodulation (2011-2021)
1.4.1 United States Neuromodulation Sales and Growth Rate (2011-2021)
1.4.2 United States Neuromodulation Revenue and Growth Rate (2011-2021)

2 United States Neuromodulation Competition by Manufacturers
2.1 United States Neuromodulation Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neuromodulation Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neuromodulation Average Price by Manufactures (2015 and 2016)
2.4 Neuromodulation Market Competitive Situation and Trends
2.4.1 Neuromodulation Market Concentration Rate
2.4.2 Neuromodulation Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Neuromodulation Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Neuromodulation Sales and Market Share by Type (2011-2016)
3.2 United States Neuromodulation Revenue and Market Share by Type (2011-2016)
3.3 United States Neuromodulation Price by Type (2011-2016)
3.4 United States Neuromodulation Sales Growth Rate by Type (2011-2016)

4 United States Neuromodulation Sales (Volume) by Application (2011-2016)
4.1 United States Neuromodulation Sales and Market Share by Application (2011-2016)
4.2 United States Neuromodulation Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Neuromodulation Manufacturers Profiles/Analysis
5.1 Medtronic, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Neuromodulation Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Medtronic, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Boston Scientific Corporation (U.S.)
5.2.2 Neuromodulation Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Boston Scientific Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 St. Jude Medical, Inc. (U.S.)
5.3.2 Neuromodulation Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 St. Jude Medical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Synapse Biomedical, Inc. (U.S.)
5.4.2 Neuromodulation Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Nevro Corporation (U.S.)
5.5.2 Neuromodulation Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Nevro Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Neurosigma, Inc. (U.S.)
5.6.2 Neuromodulation Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Neurosigma, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Neuropace, Inc. (U.S.).
5.7.2 Neuromodulation Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Neuropace, Inc. (U.S.). Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Neuronetics, Inc. (U.S.)
5.8.2 Neuromodulation Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Neuronetics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Cyberonics, Inc. (U.S.)
5.9.2 Neuromodulation Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Cyberonics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 BioControl Medical (Israel)
5.10.2 Neuromodulation Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 BioControl Medical (Israel) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 Neuromodulation Manufacturing Cost Analysis
6.1 Neuromodulation Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Neuromodulation

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Neuromodulation Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Neuromodulation Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Neuromodulation Market Forecast (2016-2021)
10.1 United States Neuromodulation Sales, Revenue Forecast (2016-2021)
10.2 United States Neuromodulation Sales Forecast by Type (2016-2021)
10.3 United States Neuromodulation Sales Forecast by Application (2016-2021)
10.4 Neuromodulation Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Tables and Figures

Figure Picture of Neuromodulation
Table Classification of Neuromodulation
Figure United States Sales Market Share of Neuromodulation by Type in 2015
Figure Internal Neuromodulation Picture
Figure External Neuromodulation Picture
Table Application of Neuromodulation
Figure United States Sales Market Share of Neuromodulation by Application in 2015
Figure Spinal Cord Stimulation Examples
Figure Deep Brain Stimulation Examples
Figure Sacral Nerve Stimulation Examples
Figure Vagus Nerve Stimulation Market Examples
Figure United States Neuromodulation Sales and Growth Rate (2011-2021)
Figure United States Neuromodulation Revenue and Growth Rate (2011-2021)
Table United States Neuromodulation Sales of Key Manufacturers (2015 and 2016)
Table United States Neuromodulation Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neuromodulation Sales Share by Manufacturers
Figure 2016 Neuromodulation Sales Share by Manufacturers
Table United States Neuromodulation Revenue by Manufacturers (2015 and 2016)
Table United States Neuromodulation Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Neuromodulation Revenue Share by Manufacturers
Table 2016 United States Neuromodulation Revenue Share by Manufacturers
Table United States Market Neuromodulation Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Neuromodulation Average Price of Key Manufacturers in 2015
Figure Neuromodulation Market Share of Top 3 Manufacturers
Figure Neuromodulation Market Share of Top 5 Manufacturers
Table United States Neuromodulation Sales by Type (2011-2016)
Table United States Neuromodulation Sales Share by Type (2011-2016)
Figure United States Neuromodulation Sales Market Share by Type in 2015
Table United States Neuromodulation Revenue and Market Share by Type (2011-2016)
Table United States Neuromodulation Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neuromodulation by Type (2011-2016)
Table United States Neuromodulation Price by Type (2011-2016)
Figure United States Neuromodulation Sales Growth Rate by Type (2011-2016)
Table United States Neuromodulation Sales by Application (2011-2016)
Table United States Neuromodulation Sales Market Share by Application (2011-2016)
Figure United States Neuromodulation Sales Market Share by Application in 2015
Table United States Neuromodulation Sales Growth Rate by Application (2011-2016)
Figure United States Neuromodulation Sales Growth Rate by Application (2011-2016)
Table Medtronic, Inc. (U.S.) Basic Information List
Table Medtronic, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Boston Scientific Corporation (U.S.) Basic Information List
Table Boston Scientific Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Corporation (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table St. Jude Medical, Inc. (U.S.) Basic Information List
Table St. Jude Medical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table St. Jude Medical, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Synapse Biomedical, Inc. (U.S.) Basic Information List
Table Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Nevro Corporation (U.S.) Basic Information List
Table Nevro Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nevro Corporation (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Neurosigma, Inc. (U.S.) Basic Information List
Table Neurosigma, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurosigma, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Neuropace, Inc. (U.S.). Basic Information List
Table Neuropace, Inc. (U.S.). Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuropace, Inc. (U.S.). Neuromodulation Sales Market Share (2011-2016)
Table Neuronetics, Inc. (U.S.) Basic Information List
Table Neuronetics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuronetics, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table Cyberonics, Inc. (U.S.) Basic Information List
Table Cyberonics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyberonics, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)
Table BioControl Medical (Israel) Basic Information List
Table BioControl Medical (Israel) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioControl Medical (Israel) Neuromodulation Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation
Figure Manufacturing Process Analysis of Neuromodulation
Figure Neuromodulation Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Major Manufacturers in 2015
Table Major Buyers of Neuromodulation
Table Distributors/Traders List
Figure United States Neuromodulation Production and Growth Rate Forecast (2016-2021)
Figure United States Neuromodulation Revenue and Growth Rate Forecast (2016-2021)
Table United States Neuromodulation Production Forecast by Type (2016-2021)
Table United States Neuromodulation Consumption Forecast by Application (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top